Raltegravir HIV drug molecule

Raltegravir HIV drug molecule

A624/0560 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 79.8MB

Downloadable file size: 461.9KB

Price image Pricing

Please login to use the price calculator


Caption: Raltegravir HIV drug, molecular model. Raltegravir (marketed as Isentress) belongs to the integrase inhibitor class of drugs used to treat human immunodeficiency virus (HIV) infections. It inhibits the enzyme integrase, which integrates the viral DNA into the human chromosome, a vital step in the virus' pathogenesis. Atoms are represented as spheres and are colour-coded: carbon (light blue), hydrogen (gold), nitrogen (dark blue), oxygen (red) and fluorine (green).

Release details: Model release not required. Property release not required.

Keywords: 1, antiretroviral, artwork, biochemical, biochemistry, chemical, chemistry, compound, compounds, cut out, cut-out, cutout, drug, hiv, human immunodeficiency virus, illustration, integrase inhibitor, isentress, medical, medicine, mk-0518, molecular, molecular model, molecule, molecules, one, person, pharmaceutical, pharmaceutics, pharmacological, pharmacology, primary structure, raltegravir, single, space fill, space-fill, spacefill, strand transfer inhibitors

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.